# US 2021/0261599 A1 · Process for the Preparation of Obeticholic Acid and Intermediates Used In the Process Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0261599 A1
- Document ID: US20210261599A1
- Status: Published application
- Kind: A1
- Application number: 17/261,647
- Filed: 2019-03-15
- Published: 2021-08-26
- Earliest claimed: 2018-08-24
- Assignees: Solara Active Pharma Sciences Limited
- Applicants: Solara Active Pharma Sciences Limited
- Inventors: Anil Ganpatrao Holkar; Vellaichamy Ganesan; Dhanapal Ramu; Manjunatha Bhat; Prasad N Patgar; Loganathan Mani; Sudarsanam Yeshaiah; Swaminathan Srinivasan; Karabasanagouda Timmanagouda
- Web page: https://patentgrep.com/patent/US20210261599A1

## CPC

- C07J 9/005: {containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton}
- C07J 75/00: Processes for the preparation of steroids in general
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07J: STEROIDS (seco-steroids C07C)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to an improved process for the preparation of Obeticholic acid and intermediates used in the process thereof. The invention also relates to a solid form of tertiary butylamine salt of Obeticholic acid and tertiary butylamine salt of Obeticholic acid in the solvate form.

## Claims

### Claim 1

A process for the preparation of Obeticholic acid of formula-I having chenodeoxycholic acid impurity less than 0.5% w/w,
said process comprising the steps of:
(i) converting the compound of formula-III or its salt thereof to a compound of formula-II or its salt thereof
in the presence of palladium carbon in aqueous alkaline medium;
(ii) reducing the compound of formula-II or its salt thereof in the presence of sodium borohydride in an aqueous alkaline medium to obtain Obeticholic acid;
(iii) treating Obeticholic acid with tertiary butylamine to obtain a tertiary butylamine salt of Obeticholic acid; and
(iv) converting tertiary butylamine salt of Obeticholic acid to Obeticholic acid of formula-I having chenodeoxycholic acid impurity less than 0.5% w/w.

### Claim 2 (depends on 1)

The process as claimed in claim 1, wherein Obeticholic acid obtained in step (iv) is the amorphous form of Obeticholic acid.

### Claim 3

A solid form of tertiary butylamine salt of Obeticholic acid.

### Claim 4 (depends on 3)

The solid form of tertiary butylamine salt of Obeticholic acid as claimed in claim 3, characterized by X-ray diffraction spectrum having peaks expressed as 28 values at about 9.8, 11.6, 13.8, 14.6, 16.9, 17.9 and 18.51±0.2 degrees.

### Claim 5

(canceled)

### Claim 6

A process for the preparation of amorphous form of Obeticholic acid comprising the step of converting tertiary butylamine salt of Obeticholic acid to amorphous form of Obeticholic acid.

### Claim 7 (depends on 6)

The process as claimed in claim 6, wherein said process comprises:
(a) adding tertiary butylamine salt of Obeticholic acid to mixture of a water and water immiscible solvent;
(b) adjusting the pH of the biphasic mixture obtained in step (a) between 2-5;
(c) separating the organic layer from the biphasic mixture obtained in step (b)
(d) adding water to the separated organic layer obtained in step (c);
(e) adding alkali carbonate or bicarbonate solution to the biphasic mixture obtained in step (d) till the pH between 9-13;
(f) separating the aqueous layer from the biphasic mixture obtained in step (e);
(g) adjusting the pH between 3-5;
(h) optionally stirring till the solid formation; and
(i) isolating the amorphous form of Obeticholic acid.

### Claim at position 8

8-14. (canceled)
